Interrupting the Pin1/CDK1/pVHL axis results in decreased cancer cell proliferation, migration, invasion, and chemoresistance, and therefore it could be therapeutically valuable in treating cancers with wild-type VHL [11]. The gene discussed is CDK1; the disease is cancer.